Dose-dependent absorption of disodium etidronate
- PMID: 2862272
- DOI: 10.1111/j.2042-7158.1985.tb03035.x
Dose-dependent absorption of disodium etidronate
Abstract
The gastrointestinal absorption of disodium etidronate (as [14C]disodium etidronate) was investigated in the rat proximal jejunum in-situ. Studies using various initial concentrations of the drug suggested that etidronate absorption occurred by passive diffusion at initial concentrations below 0.08 M. At initial concentrations above 0.08 M, the rate of absorption was significantly greater than would be expected if passive diffusion was the only mechanism responsible for absorption. Etidronate absorption is not mediated by the carrier mechanism responsible for phosphate ion absorption.
Similar articles
-
Dose-dependent effect of calcium and magnesium etidronate on salicylic acid absorption in the rat.J Pharm Pharmacol. 1985 Jun;37(6):440-2. doi: 10.1111/j.2042-7158.1985.tb03034.x. J Pharm Pharmacol. 1985. PMID: 2862271
-
Intestinal absorption of disodium ethane-1-hydroxy-1,1-diphosphonate (disodium etidronate) using a deconvolution technique.Toxicol Appl Pharmacol. 1973 Apr;24(4):580-9. doi: 10.1016/0041-008x(73)90219-6. Toxicol Appl Pharmacol. 1973. PMID: 4197358 No abstract available.
-
Absorption of oral diphosphonate in normal subjects.Clin Endocrinol (Oxf). 1986 Jan;24(1):57-62. doi: 10.1111/j.1365-2265.1986.tb03254.x. Clin Endocrinol (Oxf). 1986. PMID: 3085989
-
Histological evaluation of symptomatic ossification of the anterior longitudinal ligament treated with etidronate disodium: a case report.J Med Case Rep. 2016 Nov 10;10(1):320. doi: 10.1186/s13256-016-1100-7. J Med Case Rep. 2016. PMID: 27832809 Free PMC article.
-
Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis.Br J Clin Pract. 1996 Jan-Feb;50(1):23-31. Br J Clin Pract. 1996. PMID: 8729598 Review.
Cited by
-
Bioavailability prediction based on molecular structure for a diverse series of drugs.Pharm Res. 2004 Jan;21(1):68-82. doi: 10.1023/b:pham.0000012154.09631.26. Pharm Res. 2004. PMID: 14984260
-
Risedronate gastrointestinal absorption is independent of site and rate of administration.Pharm Res. 1998 Feb;15(2):228-32. doi: 10.1023/a:1011910517200. Pharm Res. 1998. PMID: 9523308 Clinical Trial.
-
Racial difference in bioavailability of oral ibandronate between Caucasian and Taiwanese postmenopausal women.Osteoporos Int. 2020 Jan;31(1):193-201. doi: 10.1007/s00198-019-05127-y. Epub 2019 Oct 23. Osteoporos Int. 2020. PMID: 31642977
MeSH terms
Substances
LinkOut - more resources
Full Text Sources